CVS (CVS) CFO Brian Newman receives new stock options and RSU awards

Rhea-AI Filing Summary

CVS Health EVP and CFO Brian Newman received new equity awards. He was granted stock options for 125,748 shares of common stock at an exercise price of $71.82 per share, which become exercisable in three equal annual installments starting on March 31, 2027.

Newman also received 19,493 restricted stock units of common stock at a reference price of $71.82 per share. These RSUs vest in three equal installments beginning on March 31, 2027. Following the RSU grant, he directly holds 41,354 shares of CVS Health common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Newman Brian

Role EVP, Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	125,748	$71.82	$9.03M
Grant/Award	Common Stock (RSUs)	19,493	$71.82	$1.40M

Holdings After Transaction: Stock Option — 125,748 shares (Direct); Common Stock (RSUs) — 41,354 shares (Direct)

Footnotes (1)

1. Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

Key Figures

Stock options granted: 125,748 shares Option exercise price: $71.82 per share RSUs granted: 19,493 shares +3 more

6 metrics

Stock options granted 125,748 shares Option award on March 31, 2026

Option exercise price $71.82 per share Exercise price for 125,748 options

RSUs granted 19,493 shares Restricted stock units awarded March 31, 2026

Post-grant common shares 41,354 shares Direct CVS common stock holding after RSU grant

Option vesting start March 31, 2027 First of three annual installments

Option expiration March 31, 2036 Expiration date for granted options

Key Terms

restricted stock units, 2017 Incentive Compensation Plan, Stock Option, exercise price, +1 more

5 terms

restricted stock units financial

"Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2017 Incentive Compensation Plan financial

"awarded pursuant to Issuer's 2017 Incentive Compensation Plan."

Stock Option financial

"Option becomes exercisable in three equal annual installments, commencing 3/31/2027."

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"conversion_or_exercise_price": "71.8200""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date": "2036-03-31T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Newman Brian

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RHODE ISLAND 02895

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock (RSUs)	03/31/2026		A(1)		19,493	A	$71.82	41,354	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option(2)	$71.82	03/31/2026		A		125,748		03/31/2027	03/31/2036	Common Stock	125,748	$71.82	125,748	D

Explanation of Responses:

1. Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.

2. Option becomes exercisable in three equal annual installments, commencing 3/31/2027.

	/s/ Brian Newman	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did CVS (CVS) CFO Brian Newman receive in this Form 4?

Brian Newman received a grant of stock options and restricted stock units. The option covers 125,748 shares at $71.82, and 19,493 RSUs reference the same price, providing both long-term incentive and potential ownership alignment with shareholders over time.

What is the exercise price and vesting schedule of Brian Newman’s new CVS stock options?

The stock options have an exercise price of $71.82 per share and cover 125,748 shares. They become exercisable in three equal annual installments, starting on March 31, 2027, which spreads Newman's potential share purchases over several years.

How do Brian Newman’s new CVS restricted stock units vest?

Newman’s 19,493 restricted stock units vest in three equal installments. The restrictions begin to lapse on March 31, 2027, under CVS Health’s 2017 Incentive Compensation Plan, linking his realized share ownership to ongoing service and future company performance.

How many CVS common shares does Brian Newman hold after these equity grants?

After the restricted stock unit grant, Brian Newman directly holds 41,354 CVS common shares. This figure reflects his updated ownership position reported in the filing and highlights the scale of his direct equity exposure to the company’s stock.

Are Brian Newman’s CVS equity awards part of an incentive compensation plan?

Yes, the restricted stock units were awarded under CVS Health’s 2017 Incentive Compensation Plan. This plan is designed to grant equity-based awards that align executive compensation with long-term shareholder interests and the company’s future performance trajectory.